Evidence map›Paper›PMID 42020794›Full record

ArticlePediatric research2026

Interferon-λ3 rs12979860 polymorphism and early-life RSV-bronchiolitis are associated with persistent asthma in male children: a 4-year prospective follow-up study.

Patricio Astudillo, Marcelo López-Lastra

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Patricio AstudilloLaboratorio de Virología Molecular, Instituto Milenio de Inmunología e Inmunoterapia, Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID http://orcid.org/0000-0002-2600-630X
Marcelo López-LastraLaboratorio de Virología Molecular, Instituto Milenio de Inmunología e Inmunoterapia, Departamento de Enfermedades Infecciosas e Inmunología Pediátrica, Escuela de Medicina, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. lopezlastra@uc.cl.ORCID http://orcid.org/0000-0002-7936-8478

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInterferon-lambda 3 (IFN-λ3) plays a crucial role in antiviral defense but may also influence asthma development. We hypothesized that infants carrying the rs12979860(TT) and rs8099917(GG) genotypes, associated with lower IFN-λ3 expression, who experience early-life bronchiolitis, are more susceptible to developing persistent asthma.

methodsA 4-year prospective follow-up study of a post-bronchiolitis cohort of 666 children was conducted. The primary outcome was a diagnosis of persistent asthma 4 years after discharge. IFN-λ3 SNPs information and clinical data were collected from earlier reports, medical records, and questionnaires.

results26.3% (n = 175) of the children developed physician-diagnosed asthma. Multivariate analysis identified parental history of asthma and the IFN-λ3 rs12979860(TT) genotype as independent risk factors in boys (Hazard ratio: 1.7 (95% CI: 1.04-2.98)) who experienced a Respiratory Syncytial virus (RSV)-bronchiolitis before 6 months of age. Uncontrolled asthma status at 4 years after discharge was associated with rs12979860(TT) and rs8099917(GG) genotypes in boys and girls.

conclusionThe rs12979860(TT) genotype is a sex-specific genetic risk factor for persistent asthma in boys who experience RSV-bronchiolitis before the age of 6 months, revealing a complex gene-environment-sex interaction that determines long-term respiratory outcomes. IMPACT: Asthma is a chronic, heterogeneous pulmonary disease characterized by the inflammation of the lower respiratory tract. In this study, we identify a novel genetic marker associated with IFN-λ3 expression levels, which, when combined with children's clinical history of bronchiolitis, could aid in the early identification of those at higher risk of developing asthma and of uncontrolled asthma before the age of 5.

Identifiers

PMID42020794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.